Journal News

Do sperm offer the uterus
a secret handshake?

Researchers discover endometrial receptor that can recognize surface molecule
Laurel Oldach
Jan. 22, 2020

Why does it take 200 million sperm to fertilize a single egg?

One reason: When sperm arrive in the uterus, they are bombarded by the immune system. Perhaps, molecular anthropologist Pascal Gagneux says, many are needed so some will survive. On the other hand, the female may benefit by culling so many sperm.

“I’m a lonely zoologist in a medical school,” Gagneux said. “My elevator spiel is that all of life is one big compromise. (For an egg), being too easy to fertilize is bad; being too difficult to fertilize is also bad.”

Gagneux’s lab at the University of California, San Diego, has discovered the makings of something that might be compared to a secret handshake between sperm and the cells lining the uterus in mice and, perhaps, humans. Uterine cells, they report in the Journal of Biological Chemistry, express a receptor that recognizes a glycan molecule on the surface of sperm cells. This interaction might adjust the female’s immune response and help sperm make it through the leukocytic reaction. 

JBC-news-sperm-leukocytic-resposne-(1).jpg
Tecle et al. JBC 2019
An artistic rendering (not to scale) shows how the “secret handshake” between sperm and endometrial cells takes place. The surface of sperm is coated in glycans, branched structures that are rich in sialic acid. These can be recognized by sialic acid binding receptors, called siglecs, found on the surface of endometrial cells.

The leukocytic reaction is not well understood. What we do know, Gagneux said, is that “after crossing the cervix, millions of sperm — a U.S. population worth of sperm — that arrive in the uterus are faced by a barrage of macrophages and neutrophils.” 

This attack by the innate immune system kills most of the sperm cells in semen, winnowing hundreds of millions down to just a few hundred that enter the fallopian tubes. The defensive response may help prevent polyspermy, when an egg is fertilized by more than one sperm and cannot develop.

Sperm are coated in sialic acid–rich glycans, and the innate immune system uses sialic acid to differentiate human cells from invaders, so Gagneux and his lab expected that the glycan might interact with innate immune cells called neutrophils. But human neutrophils they tested were activated to a similar degree by sperm with and without sialic acid.

Meanwhile, the team noticed sialic acid–binding receptors called siglecs on endometrial cells. In solution, these endometrial receptors can bind to whole sperm. According to Gagneux, the binding interaction might help the sperm run the gantlet of the leukocytic response — for example, by dampening the immune response. Alternatively, it may be a way for uterine cells to weed out faulty sperm. In the immune system, siglecs help cells to recognize sialic acid molecules as markers of the body’s own cells, and in that context they can turn inflammation either up or down.

“It’s somewhat embarrassing how little we can say about what this (interaction) means,” Gagneux said. To understand its physiological significance, researchers first must look for direct interaction between sperm and intact uterine tissue — this paper looked at only sperm interacting with purified proteins and isolated cells. 

It’s humbling to work in such a poorly understood area, Gagneux said. Reproduction “is a very, very delicate tug-of-war at many levels. The fact that there is (also) this immune game going on is completely fascinating.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.